The panel was moderated by Andrea Chiarello (Pfizer), Chair, Healthcare Committee, AmCham EU where members heard from Meredith Broadbent, Senior Adviser (Non-resident), Centre for Strategic and International Studies; Gloria Ghéquière, Adviser, Cabinet of Deputy Prime Minister Franck Vandenbroucke, Belgian Federal Government; and Elizabeth Kuiper, Associate Director, European Policy Centre.
Shaping the future of life sciences in Europe
What does the future hold for Europe's life sciences sector? On Tuesday, 19 September, AmCham EU explored this question, hearing policy and industry perspectives during a panel discussion. The attention was on recent legislative changes within the EU and the challenges they may pose to transatlantic cooperation on health policy. By innovating together, the EU and US can set a promising future for the life sciences sector, enhancing health policy and advancing global well-being.

Related items
:focal())
Healthcare, competitiveness, innovation and simplification
Europe’s life sciences sector sits at the heart of the EU’s competitiveness agenda. It supports advanced manufacturing and helps bring new treatments and technologies to patients. Yet companies deciding where to invest need a regulatory environment that is predictable and open to global cooperation.
The European Commission’s work on the Biotech Act and the targeted revision of the Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) offers an opportunity to improve that environment. Both files can help make Europe a stronger location for life sciences investment.
The EU should use this moment to build a framework that keeps pace with scientific progress. That means faster and clearer procedures. It also means better use of data and intellectual property rules that recognise the realities of global supply chains.
:focal())
Strengthening EU competitiveness through an adaptive MDR/IVDR framework
:focal())
A global approach to strengthening Europe’s biotechnology ecosystem
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.